BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Clinigen Release: Shaun Chilton To Take Over As Chief Executive Officer

  September 28, 2016

   · 

  3 min read
• Drug Development

  Moberg Pharma AB (Formerly known as Moberg Derma) Begins Patient Enrollment In North America And Europe In Two Phase 3 Studies Of MOB-015 In Onychomycosis

  September 28, 2016

   · 

  3 min read
• Drug Development

  Two New Trials Of Merck & Co.’s KEYTRUDA (Pembrolizumab) As Monotherapy And In Combination With Chemotherapy For First-Line Treatment Of Patients With Advanced Non-Small Cell Lung Cancer To Be Presented During Presidential Session At ESMO 2016

  September 28, 2016

   · 

  16 min read
• Pharm Country

  Pfizer To Showcase Progress Of Broad-Based Oncology Portfolio At European Society For Medical Oncology (ESMO) 2016 Congress

  September 28, 2016

   · 

  1 min read
• Drug Development

  Pfizer To Showcase Progress Of Broad-Based Oncology Portfolio At European Society For Medical Oncology (ESMO) 2016 Congress

  September 28, 2016

   · 

  1 min read
• Pharm Country

  Synergy Pharma Announces New Plecanatide Data Presentations At Upcoming Scientific Meeting And Provides Update On IBS-C Program

  September 28, 2016

   · 

  1 min read
• Biotech Beach

  Aerie To Host Investor Day On October 5, 2016

  September 28, 2016

   · 

  1 min read
• GENFIT Is Filing For IND Submission For New Indication Of Elafibranor In Primary Biliary Cholangitis (PBC)

  September 28, 2016

   · 

  3 min read
• BioMidwest

  Clovis Oncology Announces Rucaparib Data Presentations At ESMO 2016 Congress

  September 28, 2016

   · 

  1 min read
• Drug Development

  Galera Announces Presentation Of One-Year Follow-up Data From A Phase 1b/2a Study Of GC4419 In The Reduction Of Severe Oral Mucositis

  September 28, 2016

   · 

  4 min read